The first human case of avian influenza A(H9N2) has been identified in Europe, specifically in the Lombardy region of Italy, according to a statement released by the Italian Ministry of Health. This marks a significant development in monitoring avian influenza, though officials emphasize the current risk to the general public remains low. The patient, who has underlying health conditions, contracted the infection outside of Europe and is currently hospitalized.
While the discovery warrants attention, health authorities are quick to point out that the H9N2 virus is considered to be of low pathogenicity. So it’s less likely to cause severe disease in humans compared to some other influenza strains. The Ministry of Health states that, based on current scientific evidence, transmission occurs exclusively through direct contact with infected poultry or contaminated environments. There have been no reported cases, nor evidence, of person-to-person transmission. Understanding the nuances of avian influenza is crucial for public health preparedness.
First Confirmed Case in Europe Triggers Enhanced Surveillance
The identification of this case has prompted a swift response from Italian health officials. All standard verification procedures were immediately implemented, and contacts of the patient have been identified through routine prevention and surveillance activities. The Ministry of Health is coordinating closely with the Lombardy Region, the National Institute of Health (Istituto Superiore di Sanità), and national laboratory experts, as well as keeping international organizations informed. This coordinated approach is designed to contain any potential spread and gather further data on the virus.
Guido Bertolaso, the Regional Welfare Assessor for Lombardy, stated, “Thanks to the active epidemiological surveillance network in the regional territory, the first European case of avian influenza subtype H9 has been identified in a patient coming from abroad.” Region Lombardy immediately activated coordination procedures with the Ministry of Health and the National Institute of Health to ensure rigorous case management and contact monitoring.
Patient Receiving Care in Monza; Investigation Underway
The patient is currently isolated and receiving treatment at the San Gerardo Hospital in Monza. Beyond addressing the viral infection, medical staff are also managing the patient’s pre-existing health conditions. An epidemiological investigation was promptly conducted by ATS Brianza, and molecular analyses confirming the virus were performed by the University of Milan and subsequently validated by the Regional Infectious Diseases Center (composed of the Welfare Directorate – Prevention Unit of the Lombardy Region, ASST Fatebenefratelli-Sacco and San Matteo of Pavia) and the ISS.
Bertolaso emphasized that the discovery should not cause alarm among the population, stating, “The identification of the first European case of H9 influenza in Lombardy…is tangible proof that our prevention system works with extreme precision. We acted with great speed.” The focus remains on providing the best possible care for the patient and preventing further transmission.
Understanding the H9N2 Virus and Transmission Risk
Avian influenza A(H9N2) is a subtype of influenza virus that primarily affects birds. While human infections are rare, they can occur following close contact with infected poultry. The virus doesn’t readily adapt to humans, which is why widespread transmission hasn’t been observed. However, continued monitoring is essential, as influenza viruses are known to mutate. The World Health Organization (WHO) closely tracks avian influenza outbreaks globally and assesses the risk to human health.
The Italian Ministry of Health assures the public that the national surveillance system remains active and all preventative measures have been promptly initiated. This includes enhanced monitoring of poultry populations and increased vigilance among healthcare professionals. The situation is being continuously monitored for any changes or developments.
The identification of this case highlights the importance of robust public health infrastructure and international collaboration in addressing emerging infectious diseases. Early detection and rapid response are critical to minimizing the impact of potential outbreaks. For individuals traveling to areas with known avian influenza activity, it’s advisable to follow local health guidelines and avoid contact with poultry farms or markets.
The Ministry of Health will provide further updates as the situation evolves. The next scheduled update is expected within one week, following a review of contact tracing and further laboratory analysis. For the latest official information, please refer to the Ministry of Health’s website: https://www.salute.gov.it/.
We encourage readers to share this information with their communities and to remain informed about public health recommendations. Your comments and questions are welcome below.
Related reading
